Study: Estrogen therapy avoidance possible factor in nearly 50,000 deaths

07/22/2013 | HealthDay News · CBS News

A study published in the American Journal of Public Health found that avoidance of estrogen hormonal therapy was a possible factor in the deaths of almost 50,000 women who had hysterectomies and experienced menopausal symptoms over the past decade. Researchers analyzed U.S. Census data and found that the use of hormone therapy fell significantly after the publication of the 2002 U.S. Women's Health Initiative Study, which linked estrogen-progestin combination therapy to higher risk of breast cancer, heart disease, stroke and blood clots. "Sadly, the media, women, and health care providers did not appreciate the difference between [estrogen-only and estrogen-plus-progestin] hormone therapy," said health expert Dr. Philip Sarrel.

View Full Article in:

HealthDay News · CBS News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX